Twinbeech Capital LP Agios Pharmaceuticals, Inc. Transaction History

Twinbeech Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $639,741 - $887,884	-15,261 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$52.06 - $61.27 $794,487 - $935,041	15,261 New	15,261 $841,000
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $262,246 - $447,699	-8,320 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $250,265 - $420,908	8,320 New	8,320 $397,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.3B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.